Ginkgo Bioworks Holdings, Inc.

Ginkgo’s headquarters are located in the Seaport district of Boston, Massachusetts and comprise a set of non-cancellable operating leases within a facility totaling over 320,000 square feet of office and laboratory space. These lease agreements expire on dates ranging from 2030 to 2036 and each contain one option to extend the lease for a five-year period at then-market rates. Of this 320,000 square feet of leased space, none is currently subleased, with an additional 196,000 available for sublease in connection with our restructuring.

We also lease approximately 164,000 square feet of office and lab space in Cambridge, Massachusetts; Emeryville, California; and Zeist, Netherlands. This includes 32,000 square feet subleased in Emeryville through 2030, and 63,000 square feet in Cambridge with leases ending in February 2026. We have exited the Cambridge spaces in connection with our restructuring.

In April 2021, we entered into a lease, as amended, consisting of approximately 260,000 rentable square feet of new office and laboratory space being developed in Boston, Massachusetts near our headquarters. The lease commenced on April 11, 2024, with rent payments beginning in June 2024, and it will expire on the fifteenth anniversary of the rent commencement date. The lease includes an option to extend for an additional ten years at then-market rates, as well as an expansion option if the owner constructs an additional building on the property. We believe our footprint prior to this new facility is now sufficient to meet our needs, therefore, this facility is available for sublease.

We also own approximately 193,000 square feet of real property in West Sacramento, California, of which 16,000 is subleased and an additional 31,000 is available for sublease.

We intend to continue to evaluate our space needs and offer any excess space for subleasing.